The ACS Biomarker collaborates with a number of European FP7 and Dutch research consortia in the field of cardiovascular disease (EU-MASCARA, HOMAGE, BestAgeing, CTMM TRIUMPH, Circulating Cells, ENGINE, the Netherlands Heart Foundation) and private partners to drive real progress in biomarker development. The introduction of novel game-changing technology platforms creates a paradigm shift severely impacting the way molecular diagnostics are being developed. ACS Biomarker has taken the lead in linking powerful established and innovative biomarkers with disruptive detection technologies.  


We are continuously looking for parties that have cardiovascular miRNA candidate biomarkers for further validation and assay development.


If you are interested in exploring collaboration opportunities please contact ACS Biomarker via email at or call + 31 (0) 20 69 71 087.



Bookmark and Share